Roussel, H., De Guillebon, E., Biard, L., Mandavit, M., Gibault, L., Fabre, E., . . . Tartour, E. (2017). Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy. Oncoimmunology.
استشهاد بنمط شيكاغوRoussel, Hélène, et al. "Composite Biomarkers Defined By Multiparametric Immunofluorescence Analysis Identify ALK-positive Adenocarcinoma As a Potential Target for Immunotherapy." Oncoimmunology 2017.
MLA استشهادRoussel, Hélène, et al. "Composite Biomarkers Defined By Multiparametric Immunofluorescence Analysis Identify ALK-positive Adenocarcinoma As a Potential Target for Immunotherapy." Oncoimmunology 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.